ondansetron has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakırcı, Ş | 1 |
| Sağsöz, N | 1 |
| Devrim, T | 1 |
| Şahin, Y | 1 |
| Bulanık, M | 1 |
| Gözüyukarı, H | 1 |
1 other study available for ondansetron and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous
| Article | Year |
|---|---|
Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
Topics: Animals; Cabergoline; Dopamine Agonists; Endothelial Cells; Female; Humans; Ondansetron; Ovarian Hyp | 2022 |